Skip to main content

Table 3 Assessment of tissue expression of VEGF, TSP-1 and CD34.

From: Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1

 

VEGF

TSP-1

MVD (CD34)

Immunostaining score

Median

5

2

59 microvessels/mm2

(range)

2–6

0–3

16–300

Expression intensity (% of cases)

Negative

0

20

 

Weak

0

30

 

Intermediate

17

30

 

Strong

83

20

Â